Charles River Laboratories

A big thank you to Richi Childhood Cancer Foundation for the heartfelt welcome to our newest volunteers, Amanda C. and Barbara K. Your kindness fueled our commitment to supporting the #PediatricCancerCommunity. We're excited to return and assist in growing your incredible services. #LIFEatCRL

When performing sample suitability testing, determining the level of interference is crucial for accurate results. Suitability depends on two factors: LAL or rCR formula and sample dilution/concentration. Interested in learning more? Read more about factors like sample dilution and sensitivity in our guide. https://okt.to/DfTjlU #EndotoxinTesting #Sustainability #Biotechnology #QualityControl #rCR #LAL #LaboratoryEfficiency #CharlesRiverLabs #Trillium #Endosafe

Chairman of the Board, President, and Chief Executive Officer Jim Foster recently connected with Piotr Kosla, the founder of the PACS2 Research Foundation and father to Lena, who was diagnosed at 4-months-old with a life-threatening, very #raredisease. Lena is only the second child in Poland to be diagnosed with this rare disease, and 40th in the world. Soon after Lena’s diagnosis, our Leiden site in the Netherlands partnered with Piotr’s foundation, because they believed Lena could benefit from cell painting. With the help of Charles River and Lena’s fraternal twin, Zuzanna, significant progress has been made towards a treatment for Lena. We are honored to be able to collaborate with Piotr and the PACS2 Research Foundation. #LIFEatCRL

With the advent of biomedical engineering, the future of in vitro testing for therapeutics is now. Discover this revolutionary technology and how it will reduce the need for animal model testing on this month’s Sounds of Science podcast. https://okt.to/Buf0Ms

Employees in Montreal recently spent time assembling care packages for Fondation Québécoise du Cancer. The foundation is a Quebec non-profit organization that aims to improve care to Quebecers suffering from cancer, enhance the quality of life for people with cancer and that their relatives, as well as to educate the population on the fight against cancer in Quebec. Thank you to Fondation Québécoise du Cancer for hosting us! #LIFEatCRL ------------------------------------------------------------ Des employés de Montréal ont récemment passé du temps à assembler des colis de soins pour la Fondation Québécoise du Cancer. La fondation est un organisme québécois à but non lucratif qui vise à améliorer les soins aux Québécois atteints de cancer, à rehausser la qualité de vie des personnes atteintes de cancer et de celles de leurs proches, ainsi qu'à sensibiliser la population à la lutte contre le cancer au Québec. Merci à la Fondation Québécoise du Cancer de nous accueillir! #LIFEatCRL

Analytical chemist Bo Tokarski traded his lab coat for a four-week sabbatical with BrightEdge, the American Cancer Society’s innovation and impact investment arm. Learn more about his #sabbatical experience here: https://okt.to/xQMblW

During the Riyadh Global Medical Biotechnology Summit, Kerstin Dolph joined a panel of industry experts to discuss the importance of strategy to drive biotech advancements in emerging markets and the crucial aspects of balancing rapid innovation needs alongside regulatory compliance and patient safety. The #RGMBS conference facilitated the signing of a Memorandum of Understanding with King Abdullah International Medical Research Center (كيمارك KAIMRC), focused on sharing expertise and specialized resources in basic, clinical, and translational medical research. This follows recent news of our cell and gene therapy CDMO expansion into the GCC region through a collaboration with Lafana Holding and the launch of our Saudi Cell and Gene Therapy Accelerator program. Discover more: https://okt.to/Og83ML Dr. Ramin Baghirzade

Congratulations, Andrew Leaver! This is a well deserved honor and we are proud of your dedication to fostering #inclusivity. #LIFEatCRL

Join Matthew Hewitt and industry experts on November 20th as they explore how to advance gene editing platforms during Alliance for Regenerative Medicine's FDA Scientific Exchange 2024: Advancing Gene Editing Platforms for Rare Diseases. Register today: https://bit.ly/3OdWO2h ISCT, International Society for Cell & Gene Therapy #ARM #ISCT #CGT #celltherapy #genetherapy #CDMO #ATMP #regulatory #RareDisease